IQBAL DHANANI: Open Payments
NPI 1972674190 · COLLEGE PARK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,191 in 68 payments from 8 companies in 2025. Trend: 2023 $807 · 2024 $1,234 · 2025 $2,191
Food & beverage: $2,185Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 19 | $625 |
| Neurocrine BioSciences, Inc. | 18 | $580 |
| Teva Pharmaceuticals USA, Inc. | 12 | $368 |
| Otsuka America Pharmaceutical, Inc. | 11 | $221 |
| E.R. Squibb & Sons, L.L.C. | 3 | $173 |
| Luye Pharma (USA) Ltd. | 2 | $153 |
| ABBVIE INC. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: INGREZZA, INVEGA SUSTENNA, SPRAVATO, UZEDY, COBENFY, REXULTI, ERZOFRI EXTENDED-RELEASE, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
